
Restaurants use unsafe colouring agent: Karnataka minister on quality food
He cited the recent testing of six samples belonging to the Empire Group of Restaurants, which turned out to be unsafe due to the use of banned synthetic colouring.
"Despite repeated warnings, the restaurant group continued to use the unsafe colouring agent. Only after legal notices were sent did the colour go from red to yellow," the health minister told reporters during his weekly media briefing.
There was no response from the Empire Group of Restaurants.
According to the minister, better quality food and drugs can become the norm only if people insist on quality goods.
"Yes, the government needs to do its part and tackle this legally, but people too should cultivate quality conscious as culture," he said.
The minister also said the health department held a video conference on July 30 with cooking oil manufacturers to insist that the trans-fat level should not exceed 2 per cent.
"We told them that if it exceeds 2 per cent, strong action will be taken against them," he added.
Dinesh Gundu Rao said the oil manufacturers were also urged to sell used cooking oil (UCO) to manufacturers like Pyrene Industries, which converts UCO into biodiesel.
According to 2024-25 data, 28,73,124 litres of UCO were used to manufacture biodiesel and soap, he said.
"We want this figure to increase substantially so that UCO does not go back into the market for cooking purposes," he added.
Rao said the Karnataka government has merged the enforcement division of Ayurveda, Siddha and Unani (ASU) medicines under the AYUSH Department, as well as the existing AYUSH drug testing laboratory in Bengaluru, with Drug Control Division of the Food Safety and Drug Administration Department for better functioning of the Health Department.
According to him, the government's proposed app to control drug safety is expected to be functional by the end of this month.
"With this app, we can immediately withdraw defective drugs, as we can track at distributor level. So, we can put an immediate stop to further sale of that drug," said the minister.
He said, once the app is in force, they will expand its scope. "Next will be to take it to the pharmacy level. We want to onboard every pharmacy on the app," he added.
At present, the recall procedure takes two days, he said, citing the recent recall of nearly 40 lakh drugs in two days.
"This too, we had made a breakthrough with the help of a software. Earlier, it used to take nearly 30 days to recall batches of failed drugs from the market," he added.
The minister also said work is progressing at expected pace in bringing the private ambulances and mobile medical units under the ambit of Karnataka Private Medical Establishments (KPME) Act. "We will be coming out with an amendment soon," he added.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Print
an hour ago
- The Print
India hosts senior physicians, policymakers from BIMSTEC countries in National Cancer Grid meet
The Bay of Bengal Initiative for Multi-Sectoral Technical and Economic Cooperation (BIMSTEC) is a regional organisation that was established in 1997 with the signing of the Bangkok Declaration. 'The initiative will help our BIMSTEC partners build their capacities in the critical area of cancer care, with the expertise and skills developed in India,' the Ministry of External Affairs said in a statement. New Delhi, Aug 6 (PTI) Researchers, patient advocates and policy makers from BIMSTEC countries gathered in India as part of the annual meeting of the National Cancer Grid (NCG) to review progress and chart the course for future collaborative efforts, officials said on Wednesday. Initially known as BIST-EC (Bangladesh-India-Sri Lanka-Thailand Economic Cooperation), the organisation is now known as BIMSTEC and comprises seven Member States, with the admission of Myanmar later in 1997, and Bhutan and Nepal in 2004. The sixth BIMSTEC Summit was held in April in Bangkok. 'As part of fulfilling the promise by the Prime Minister of India at the 6th BIMSTEC Summit to help BIMSTEC countries in cancer care, India hosted senior physicians and policy makers from BIMSTEC countries at the annual meeting of the National Cancer Grid on August 2-3, 2025, at Tata Memorial Hospital, Mumbai,' the MEA said. The meeting of cancer centre directors, researchers, patient advocates and policy makers from India and around the world showcased the breadth of NCG's initiatives, reviewed progress, and charted the course for future collaborative efforts, it said in the statement. PTI KND NSD NSD This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.


News18
3 hours ago
- News18
Fortis Healthcare Q1 net profit jumps 57 pc to Rs 260 cr
Agency: PTI Last Updated: New Delhi, Aug 6 (PTI) Fortis Healthcare on Wednesday posted a 57 per cent increase in profit after tax at Rs 260 crore in the June quarter of FY26. The healthcare provider reported a profit after tax (PAT) of Rs 166 crore in the April-June quarter of last fiscal. Revenue increased to Rs 2,167 crore during the period under review as compared to Rs 1,859 crore in the year-ago quarter, Fortis Healthcare said in a statement. 'We have witnessed a healthy start to the financial year, as demonstrated in our Q1 earnings for both hospital and diagnostic businesses," Ashutosh Raghuvanshi, MD and CEO, Fortis Healthcare, stated. The recently executed O&M (operation & management) services agreement with Gleneagles India expands company's geographic footprint and provides an opportunity to leverage combined strengths to optimize operations and enhance efficiencies, he added. The company also consummated the acquisition of Shrimann Superspecialty Hospital in Jalandhar, further strengthening presence in Punjab region with around 1,000 beds, it said. 'In the diagnostics business, we have witnessed a strong recovery in both revenues and EBITDA margins, which is reflective of the brand building initiatives undertaken over the last few quarters. We expect this growth momentum to continue going forward," Raghuvanshi stated. PTI MSS HVA view comments First Published: August 06, 2025, 22:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.


News18
3 hours ago
- News18
WHO updates recommendations on use of antibiotics for COVID-19 patients
New Delhi, Aug 6 (PTI) The WHO has recommended against the use of antibiotics even in patients with severe Covid when a concurrent bacterial infection is not suspected. The global health body has released updated recommendations for the clinical management of people with Covid which, it said, are based on evidence generated from recent meta-analysis of outcomes of patients treated with antibiotics for Covid. 'For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics. For patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we suggest no empirical antibiotics," the WHO said. The WHO said that as COVID-19 epidemiology and severity have changed, and as emergency measures have subsided, the evidence behind a number of recommendations has changed. In parallel, evolution of health systems and the global environment have meant that the recommendations are implemented in a very different context in 2024 compared to 2020. These guidelines have evolved from the first version in 2020 in line with new information and changing circumstances of the pandemic, the WHO said. 'Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity. Emergency measures which were imposed have also been removed, and care for patients with COVID-19 has become more integrated with usual healthcare systems. 'This different environment has prompted a review of the scope and content of all existing guidance. In order to maintain a clear focus and relevance, we have removed recommendations which would be considered general medical principles, and those which are no longer specific to the management of COVID-19," the WHO said. The new recommendations on use of antibiotics were prompted by the publication of data from a systematic review and meta-analysis, and the pressing need to address antimicrobial resistance. The WHO said that the updated guidelines are for people directly or indirectly involved in the health care of patients with COVID-19 and post COVID-19 condition. This includes clinicians, allied health care workers, facility managers and hospital administrators. The SARS-CoV-2 continues to infect several thousands of people daily leading to preventable morbidity and mortality across the world, the WHO said. The roll-out of vaccines and treatment for COVID-19, and increasing population immunity from infection has substantially reduced hospitalization, severity of disease, and mortality. 'However, the virus continues to evolve in terms of infectivity, immune escape, and disease severity. This guideline robustly and transparently addresses the changing landscape and evidence availability, and the continual development of treatment and management strategies for COVID-19," the WHO stated. PTI PLB ZMN view comments First Published: August 06, 2025, 22:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.